StockData
Luxfer Holdings PLC logo

Luxfer Holdings PLC (LXFR) stock analysis

LXFRNYSEIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3091% above fair value
$17.34+0.00 (0.00%)

Close on Nov 13, 2026Market cap $464.01MP/E 75.4Yield –

StockData Score

Prices as of Nov 13, 2026How the score works

Value0Growth1Performance2Health6Dividend2

Mixed11 of 30 checks passed

Luxfer passes 11 of the 30 checks behind our score; 2 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
2/6
Financial health
6/6
Dividend
2/6

What stands out

  • Low debt

    Debt is 26.0% of shareholders' equity, under the 40% we consider low.

  • Interest well covered

    Operating income covers interest expense 6.6 times.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 52.0% of total debt.

  • Low bankruptcy risk

    The Altman Z-score is 3.57; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 90.7% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $17.34 is above our fair value estimate of $9.09.

  • Return on equity under 15%

    Return on equity was 2.7% over the last twelve months and averaged 8.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.5%, below the 10% that usually covers the cost of capital.

Valuation0/6
  • P/E above its 5-year median

    Luxfer's P/E of 75.4 is above its own 5-year median of 19.0.

  • P/E above the industry

    Luxfer's P/E of 75.4 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA above its 5-year median

    Luxfer's EV/EBITDA of 22.4 is above its 5-year median of 10.2.

  • P/B above the industry

    Luxfer's price-to-book of 2.09 is above the Chemicals and Allied Products median of 1.22.

  • Trading above fair value

    The share price of $17.34 is above our fair value estimate of $9.09.

  • Margin of safety under 20%

    The price is 90.7% above fair value, so there is no margin of safety.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew -3.2% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -34.1% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -56.6% over the last twelve months, against a 5-year average of -17.4% a year.

  • Growing slower than the industry

    Revenue grew -11.8% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 25.1% over the last twelve months, against 22.8% a year earlier.

Past performance2/6
  • Return on equity under 15%

    Return on equity was 2.7% over the last twelve months and averaged 8.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.5%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Luxfer's return on equity of 2.7% is above the Chemicals and Allied Products median of -0.8%.

  • Earnings shrank over 5 years

    Net income shrank 17.4% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 1.7% over the last twelve months, against a 5-year average of 4.1%.

  • Net margin above the industry

    Luxfer's net margin of 1.7% is above the Chemicals and Allied Products median of -0.4%.

Financial health6/6
  • Low debt

    Debt is 26.0% of shareholders' equity, under the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 32.0% five years ago to 26.0%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 52.0% of total debt.

  • Interest well covered

    Operating income covers interest expense 6.6 times.

  • Short-term assets cover short-term debts

    Current assets are 2.47 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.57; above 3 is the safe zone and below 1.8 the distress zone.

Dividend2/6
  • Pays a dividend

    Luxfer paid dividends worth 2.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 2.2% yield is below the 4.7% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Luxfer yields 2.2%.

  • Dividend stability

    Fewer than five years of dividend history.

  • Not covered by earnings

    Dividends take 221% of net income, leaving little room.

  • Covered by free cash flow

    Dividends take 72.5% of free cash flow.

Scores of similar companies

Our estimate per share

$9.09

The share price is 91% above this estimate.

20%+ below
Near fair value
20%+ above
$17.34Price$9.09Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E22.1×19.0×25.2×$5.0840%
EV/EBITDA15.8×10.2×21.4×$11.7935%
P/B1.5×1.7×1.2×$12.2910%
Earnings power9.2% cost of equity––$11.3615%
Fair value$9.09100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 19.0
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$9.25M
Value traded per 1% price move
$42.51M

Downside

Medium risk

Typical loss in a bad month
24.0%
Volatility (annualized)
31%
Sharpe ratio, 1 year
1.19
Beta to the S&P 500 (5Y)
0.82

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2015 to 2025

Gross margin

23.2%−1.7 pts over 5 years

Operating margin

6.2%−2.5 pts over 5 years

Net margin

2.0%−4.2 pts over 5 years

See a number that looks wrong?